Argus Investors Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $567K | Sell |
1,567
-384
| -20% | -$131K | 0.44% | 52 |
|
|
2026
Q1 | $686K | Buy |
1,951
+617
| +46% | +$220K | 0.61% | 43 |
|
|
2025
Q4 | $437K | Hold |
1,334
| – | – | 0.35% | 68 |
|
|
2025
Q3 | $376K | Sell |
1,334
-1,434
| -52% | -$416K | 0.3% | 74 |
|
|
2025
Q2 | $773K | Sell |
2,768
-1
| -0% | -$283 | 0.55% | 47 |
|
|
2025
Q1 | $863K | Sell |
2,769
-905
| -25% | -$267K | 0.66% | 43 |
|
|
2024
Q4 | $958K | Sell |
3,674
-152
| -4% | -$45.1K | 0.64% | 48 |
|
|
2024
Q3 | $1.23M | Sell |
3,826
-921
| -19% | -$301K | 0.8% | 39 |
|
|
2024
Q2 | $1.48M | Sell |
4,747
-891
| -16% | -$262K | 0.91% | 35 |
|
|
2024
Q1 | $1.6M | Sell |
5,638
-648
| -10% | -$190K | 0.98% | 35 |
|
|
2023
Q4 | $1.81M | Buy |
6,286
+9
| +0.1% | +$2.45K | 1.16% | 28 |
|
|
2023
Q3 | $1.69M | Buy |
6,277
+177
| +3% | +$44.2K | 1.22% | 27 |
|
|
2023
Q2 | $1.35M | Buy |
6,100
+180
| +3% | +$41.8K | 0.94% | 49 |
|
|
2023
Q1 | $1.43M | Hold |
5,920
| – | – | 1.08% | 42 |
|
|
2022
Q4 | $1.55M | Hold |
5,920
| – | – | 1.25% | 32 |
|
|
2022
Q3 | $1.33M | Sell |
5,920
-1,960
| -25% | -$475K | 1.19% | 34 |
|
|
2022
Q2 | $1.92M | Sell |
7,880
-395
| -5% | -$96.8K | 1.42% | 26 |
|
|
2022
Q1 | $2M | Sell |
8,275
-1,976
| -19% | -$454K | 1.28% | 31 |
|
|
2021
Q4 | $2.31M | Sell |
10,251
-48
| -0.5% | -$10.1K | 1.39% | 25 |
|
|
2021
Q3 | $2.19M | Sell |
10,299
-5,466
| -35% | -$1.26M | 1.43% | 27 |
|
|
2021
Q2 | $3.84M | Sell |
15,765
-955
| -6% | -$235K | 1.56% | 37 |
|
|
2021
Q1 | $4.16M | Sell |
16,720
-519
| -3% | -$124K | 1.68% | 36 |
|
|
2020
Q4 | $3.96M | Sell |
17,239
-2,604
| -13% | -$600K | 1.74% | 29 |
|
|
2020
Q3 | $5.04M | Buy |
19,843
+1,240
| +7% | +$307K | 2.09% | 14 |
|
|
2020
Q2 | $4.39M | Sell |
18,603
-346
| -2% | -$78.9K | 2.13% | 12 |
|
|
2020
Q1 | $3.84M | Sell |
18,949
-529
| -3% | -$116K | 2.29% | 10 |
|
|
2019
Q4 | $4.7M | Sell |
19,478
-2,080
| -10% | -$458K | 2.14% | 11 |
|
|
2019
Q3 | $4.17M | Sell |
21,558
-2,375
| -10% | -$456K | 2.02% | 23 |
|
|
2019
Q2 | $4.41M | Buy |
23,933
+1,787
| +8% | +$320K | 2.12% | 18 |
|
|
2019
Q1 | $4.21M | Sell |
22,146
-39
| -0.2% | -$7.45K | 2.01% | 22 |
|
|
2018
Q4 | $4.32M | Sell |
22,185
-2,522
| -10% | -$492K | 2.26% | 6 |
|
|
2018
Q3 | $5.12M | Sell |
24,707
-365
| -1% | -$71.9K | 2.2% | 9 |
|
|
2018
Q2 | $4.63M | Buy |
25,072
+1,284
| +5% | +$227K | 2.11% | 15 |
|
|
2018
Q1 | $4.43M | Buy |
23,788
+514
| +2% | +$94.4K | 2.19% | 5 |
|
|
2017
Q4 | $4.05M | Sell |
23,274
-514
| -2% | -$91K | 1.87% | 42 |
|
|
2017
Q3 | $4.43M | Sell |
23,788
-2,700
| -10% | -$478K | 2.19% | 5 |
|
|
2017
Q2 | $4.56M | Buy |
26,488
+498
| +2% | +$81K | 2.05% | 13 |
|
|
2017
Q1 | $4.26M | Sell |
25,990
-5,800
| -18% | -$964K | 1.99% | 18 |
|
|
2016
Q4 | $4.65M | Buy |
31,790
+5,150
| +19% | +$775K | 1.94% | 25 |
|
|
2016
Q3 | $4.44M | Sell |
26,640
-1,525
| -5% | -$258K | 1.87% | 35 |
|
|
2016
Q2 | $4.29M | Sell |
28,165
-2,000
| -7% | -$311K | 1.81% | 40 |
|
|
2016
Q1 | $4.52M | Hold |
30,165
| – | – | 1.89% | 33 |
|
|
2015
Q4 | $4.9M | Sell |
30,165
-2,100
| -7% | -$330K | 2.08% | 16 |
|
|
2015
Q3 | $4.46M | Sell |
32,265
-100
| -0.3% | -$15.8K | 1.94% | 30 |
|
|
2015
Q2 | $4.97M | Buy |
32,365
+895
| +3% | +$143K | 2.04% | 26 |
|
|
2015
Q1 | $5.03M | Buy |
31,470
+385
| +1% | +$60.6K | 2.02% | 28 |
|
|
2014
Q4 | $4.95M | Sell |
31,085
-4,765
| -13% | -$742K | 2.04% | 28 |
|
|
2014
Q3 | $5.04M | Sell |
35,850
-2,020
| -5% | -$264K | 2.11% | 18 |
|
|
2014
Q2 | $4.48M | Sell |
37,870
-880
| -2% | -$102K | 1.87% | 45 |
|
|
2014
Q1 | $4.78M | Sell |
38,750
-800
| -2% | -$97K | 1.96% | 28 |
|
|
2013
Q4 | $4.51M | Hold |
39,550
| – | – | 1.84% | 40 |
|
|
2013
Q3 | $4.43M | Sell |
39,550
-9,370
| -19% | -$1.02M | 2% | 26 |
|
|
2013
Q2 | $4.83M | Buy |
+48,920
| New | +$5.08M | 2.1% | 13 |
|
Other funds holding AMGN
Argus Investors Counsel's AMGN Position: Q2 2026 in Review
Argus Investors Counsel reduced its Amgen (AMGN) stake by 20% in Q2 2026, selling an estimated $131K and leaving 1,567 shares worth $567K. The position accounts for 0.44% of the portfolio, ranked #52.
Argus Investors Counsel first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.12M in Q3 2018. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Argus Investors Counsel held 1,567 shares of Amgen worth $567K as of Q2 2026.
- Argus Investors Counsel sold 384 Amgen shares in Q2 2026, an estimated $131K.
- Amgen made up 0.44% of Argus Investors Counsel's portfolio in Q2 2026, its #52 holding.
- Argus Investors Counsel first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- Argus Investors Counsel's Amgen position peaked at $5.12M in Q3 2018.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Argus Investors Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.